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Background: Melia azedarach L. is an important medicinal plant that is used for variety of ailments in Iranian
traditional medicine. Azadirachta indica A. Juss is its allied species and possesses similar properties and effects. The
present study was undertaken to investigate anticancer activity of these M. azedarach in comparison with A. indica
on cancer cell lines and also to evaluate their safety in humans by testing them on normal cell line. The study also
aimed to determine the active components that are responsible for medicinal effects of M. azedarach in traditional
usages.
Methods: In this study, the cytotoxic activity of crude extracts from M. azedarach and A. indica leaves, pulps and
seeds as well as three main fractions of their leaf extracts were assayed against HT-29, A-549, MCF-7 and HepG-2
and MDBK cell lines. MTT assay was used to evaluate their cytotoxic activities. Methanol leaf fraction of M.
azedarach as the safest leaf fraction in terms of cytotoxicity was subjected for phytochemical study.
Results: Results of the present study indicated that seed kernel extract of M. azedarach had the highest cytotoxic
activity and selectivity to cancer cell lines (IC50 range of 8.18- 60.10 μg mL-1). In contrast to crude seed extract of A.
indica, crude pulp and crude leaf extracts of this plant showed remarkably stronger anti-prolifrative activity
(IC50 ranges of 83.45 - 212.16 μg mL-1 and 34.11- 95.51 μg mL-1 respectively) than those of M. azedarach (all IC50
values of both plants > 650 μg mL-1). The phytochemical analysis led to the isolation of four flavonol 3-O-glycosides
including rutin, kaempferol-3-O-robinobioside, kaempferol-3-O-rutinoside and isoquercetin along with a purin
nucleoside, β-adenosine.
Conclusions: The anti-prolifrative potentials of extracts from different parts of M. azedarach and A. indica were
determined. By comparison, methanol leaf fraction of M. azedarach seems to be safer in terms of cytotoxicity. Our
study shows that flavonols are abundant in the leaves of M. azedarach and these compounds seem to be
responsible for many of medicinal effects exploited in the traditional uses.
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Melia azedarach L. (Meliaceae), commonly known as
Persian lilac or chinaberry, has long been recognized in
Iran as a medicinal plant with a variety of medicinal ef-
fects and mentioned in ancient medical literatures as
“Azad derakht” [1,2]. Table 1 presents a review on Iranian
ancient literatures on the various traditional uses of diffe-
rent parts of M. azedarach. Persian lilac is widely distrib-
uted in northern forests of Iran and has been also found
to possess outstanding antifeedant, anti-insect and cyto-
toxic activities. Most of the former studies reported
limonoids as responsible compounds for mentioned
activities of M. azedarach [3,4], Azadiracta indica A.
Juss (neem), another species from Meliaceae, is a close
relative of M. azedarach. Neem is originally native to
South India and Myanmar. However, it abundantly
grows in southern coast of Iran and is popularly known
as “Charish” there [3,5]. Neem and Persian lilac are very
similar in morphology, constituents and properties [6,7]
so that they were erroneously mixed with each other
many times [1,4]. Neem is similarly known worldwide
as commercial natural insecticide, pesticide and agro-
chemical [5] and is abundant in cytotoxic limonoids [4].
In Iranian traditional medicine, just whole plants or
mixtures of them are used and there is a belief that pure
compounds even plant-derived ones have no natural
properties like whole plants [8]. Therefore, cytotoxic
evaluation of crude extracts can gives us better insight
into cytotoxic effects of whole plants. In all studied trad-
itional literatures except one [9], fruits of M. azedarach
have been mentioned as the plant toxic and fatal part
[2,10-12]. It has been stated that they are harmful to the
stomach and chest muscles [10,11]. Recent studies also
support toxicity of the fruit [13]. TetranortriterpenesTable 1 Traditional uses of M. azedarach
Plant part Traditional uses
Flower Remedy for brain obstructions [2,10-12]
Temperament normalizer in elderly people and people
how suffer from cold dystemperament; headache and
other head pains reliever (through inhalation of its
sent) [2];
Leaf Antidote against all type of toxins [2-11];
Remedy for chronic intestinal obstructions [9-12];
Purulent sores [2,10];
Anthelmintic; remedy for kidney stones; treatment of
leprosy and vitiligo [2];
Low back pain reliever; diuretic; emmenagogue [2,12];
Hair growth inducer [2,9-12];
Lice killer [2,10-12];
Fruit Treatment of leprosy and vitiligo; remedy for tinea and
head wounds; hair growth inducer [2];
Phlegmatic fevers and coughs reliever [9].known as meliatoxins have been reported as toxic prin-
ciples of the fruit [14]. In contrast to the limitation in
fruit consumption, leaves of the plant have been pre-
scribed for a variety of indications. Therefore, in order to
detailed investigation of the leaves, their main fractions
were also studied and the methanol leaf fraction of M.
azedarach was selected for isolation of active compounds.
In the present study, crude extract of leaves, pulps
and seeds of M. azedarach and A. indica as well as dif-
ferent fractions of their leaves were studied against four
cancer cell lines (HT29, A549, MCF7 and HepG2) and
one normal cell line (MDBK). It is noteworthy that our




UV spectra were recorded on an Optizen 2120UV plus
UV/VIS spectrophotometer. NMR was run on a Bruker
DRX-500 spectrometer (1H, 500 MHz; 13C, 125 MHz).
Semi-preparative HPLC was carried out with a
KNAUERHPLC system (Germany) and Eurospher 100–
7 RP C18 (250 × 20 mm; Macherey Nagel) column.
Silica gel (35–70, 70–230 and 230–400 mesh, Merck)
and Sephadex LH20 (Fluka BioChemika, 25–100 μm)
were used for column chromatography. TLC analysis
was performed on Silica gel 60 F254 or Silica gel 60 RP-
18 F254S; Merck plates (10 × 10 cm).
Plant material
Leaves and fruits of M. azedarach and A. indica were
collected from Gorgan (Golestan Province) and Bandar
Abbas (Hormozgan Province) respectively. Then, their
voucher specimens were deposited at the Herbarium
of Faculty of Pharmacy, Tehran University of Medical
Sciences, Tehran, Iran (Voucher No. of M. azedarach:
6710 THE; Voucher No. of A. indica: 6640 THE).
Collected leaves and fruits were separately dried in
shade, at room temperature. The dried fruits were de-
husked and decorticated and their seed kernels were
separated from their husks and pulps. The leaves, pulps
of fruits (together with their husks), and seed kernels of
each plant were separately crushed into fine powders.
Preparation of extracts for cytotoxic assay
Percolation technique by methanol/water (80:20, v/v) at
room temperature was used for total extraction of the
leaves, pulps and seed kernels of two species. The extrac-
tion procedure included three consecutive extractions of
48 hours, using fresh solvent each time. The solvent was
evaporated under reduced pressure to dry. Both dried leaf
extracts fractionated with n-hexane (in order to remove
the fatty materials and chlorophylls), chloroform, ethyl
acetate and methanol successively. After evaporating
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trace solvents. To prepare different concentrations of each
extract (650 or 1000 μg/mL) for cytotoxic assay, DMSO
10% was used.
Extraction and isolation
The powdered leaves (1.20 kg) of Melia azedarach were
extracted three times (every 48 hours) with 80% metha-
nol at room temperature. The solvent was evaporated at
reduced pressure to yield 332.4 g of a crude extract. This
extract was fractionated on silica gel (35–70 mesh) using
four solvents - hexane, chloroform, ethyl acetate and
methanol- successively. The solvent in each extract was
completely evaporated under reduced pressure to yield
28.9 g (8.70%), 56.5 g (16.99%), 14.3 g (4.31%), and 220.0
g (66.18%), respectively. Then, to isolate the pure com-
pounds, methanol fraction was subjected to chromatog-
raphy on a silica gel column (70–230 mesh; 10×15 cm)
eluted with gradient of AcOEt/MeOH (100% AcOEt to
100% MeOH). The chromatographic process was moni-
tored by TLC. TLC sheets were developed using BAW
system (n-BuOH/HOAc/H2O, 3:3:1), viewed under UV
light and then sprayed with anisaldehyde-sulphuric acid
reagent. Similar fractions were pooled together to give
five fractions (M1-M5). Fractions M3 (28.7 g), collected
with AcOEt/MeOH (5:5), was chromatographed again
on a silica gel column (230–400 mesh; 5×15 cm) with a
gradient of AcOEt/MeOH (9:1 to 1:9) to give three frac-
tions (M3a- M3d). Spraying with anisaldehyde-sulphuric
acid reagent revealed a group of yellow spots on the
TLC plate of M3b.
This fraction was repeatedly chromatographed over
Sephadex LH 20 (eluted with MeOH) and monitored by
TLC until separation of yellow spots from non-target
compounds (e.g. polysaccharides). Finally, three fractions
were obtained: M3b1- M3b3.
Fraction M3b2 (272.7 mg) was fractionated by reversed-
phase HPLC with a step gradient of acetonitril/water (9:1,
8:2, 7:3, 1:9) to give the following compounds: 1 (2.3 mg),
2 (101.9 mg), 3 (20.1 mg) and 4 (16.1 mg). M3b3 was pu-
rified by Sephadex LH 20 chromatography again to yield
compound 5 (14.1 mg);
(1) 9β-D-ribofuranosyladenine (β-adenosine)
Rf values ×100: 52 (system: BAW (n-BuOH:HOAc:
H2O, 3:3:1)); ninhydrin and dragendrof-positive
compound; 1H-NMR (DMSO-d6): δ 8.34 (1H, s, H-8),
8.12 (1H, s, H-2), 7.34 (2H, bs, NH2) 5.85 (1H, d, J = 6
Hz, H-1'α), 5.46 (2H, bs, OH-2', OH-5'), 5.25 (2H, bs,
OH-3'), 4.59 (1H, bs, H-2'), 4.12 (1H, bs, H-3'), 3.94
(1H, d, J = 3, H-4'), 3.66 (1H, bs, H-5'a), 3.52 (1H, bs, H-
5'b). 13CNMR (DMSO-d6): δ 156.23 (C-6), 152.49 (C-
2), 149.11 (C-4), 140.03 (C-8), 119.41 (C-5), 87.98 (C-
1'), 85.99 (C-4'), 73.53 (C-2'), 70.74 (C-3'), 61.75 (C-5').(2) Quercetin-3-O-rutinoside (Rutin)
Amorphous yellow powder, Rf values ×100: 57
(system: BAW (n-BuOH: HOAc: H2O, 3:3:1);
1H-NMR (DMSO-d6): δ 12.52 (1H, s, OH-5), 7.55
(2H, d, J = 8 Hz, H-2' and H-6'), 6.85 (1H, d, J = 8
Hz, H-5'), 6.39 (1H, J = 2 Hz, H-8), 6.20 (1H, J = 2
Hz, H-6), 5.34 (1 H, d, J = 7 Hz, H-1'' anomeric
proton of glucosyl), 4.40 (1H, bs, H-1''' anomeric
proton of rhamnosyl), 3.06-3.72 (m, remaining sugar
protons) and 0.99 (3H, d, J = 6 Hz, CH3 rhamnosyl).
13C NMR (DMSO-d6): δ 177.36 (C-4); 164.45 (C-7);
161,25 (C-5); 156.65 (C-9); 156.47 (C-2); 148.50
(C-4'), 144.81 (C-3'); 133.30 (C-3); 121.64 (C-6');
121.18 (C-1'); 116.27 (C-5'); 115.27 (C-2'); 103.88
(C-10); 101.24 (C-1''); 100.80 (C-1'''); 98.82 (C-6);
93.69 (C-8); 76.46 (C-3''); 75.92 (C-5''); 74.11 (C-2'');
71.87 (C-4'''), 70.59 (C-2'''), 70.41 (C-3'''), 70.02
(C-4''); 68.31 (C-5'''), 67.04 (C-6''); and 17.80 (C-6''').
(3) Kaempferol-3-O-robinobioside
Amorphous yellow powder, Rf values ×100: 60
(system: BAW (n-BuOH: HOAc: H2O, 3:3:1));
1H-NMR (DMSO-d6): δ 12.52 (1H, s, OH-5), 8.04
(2H, d, J= 8 Hz, H-2' and H-6'), 6.86 (2H, d, J= 8 Hz,
H-3' and H-5'), 6.34 (1H, bs, H-8), 6.13 (1H, bs, H-6),
5.28 (1H, d, J= 7.7 Hz, H-1'' anomeric proton of
galactosyl), 4.40 (1H, bs, H-1''' anomeric proton of
rhamnosyl), 3.08 - 3.61 (m, remaining sugar protons)
and 1.07 (3H, d, J= 6 Hz, CH3 rhamnosyl).13C NMR
(DMSO-d6): δ 177.10 (C-4); 164.4 (C-7); 161.10
(C-5); 160.00 (C-4'), 156.64 (C-9); 156.23 (C-2);
133.23 (C-3); 130.90 (C-2', C-6'); 120.87 (C-1');
115.08 (C-3', C-5'); 103.4 (C-10); 102.31 (C-1'');
100.07 (C-1'''); 98.8 (C-6); 94.06 (C-8); 73.49 (C-5'');
73.03 (C-3''); 71.92 (C-4'''), 71.12 (C-2''), 70.42, 70.62
(C-2''',C-3'''), 68.29 (C-5'''), 68.01 (4''); 65.32 (C-6'');
and 17.92 (C-6''').
(4) Kaempferol-3-O-rutinoside
Yellow crystals, Rf values ×100: 65 (system: BAW
(n-BuOH: HOAc: H2O, 3:3:1));1H-NMR
(DMSO-d6): δ 12.54 (1H, s, OH-5), 7.98 (2H, d, J = 9
Hz, H-2' and H-6'), 6.88 (2H, d, J = 9 Hz, H-3' and
H-5'), 6.38 (1H, bs, H-8), 6.18 (1H, bs, H-6), 5.30
(1H, d, J= 7.5 Hz, H-1'' anomeric proton of
glucosyl), 4.38 (1H, bs, H-1''' anomeric proton of
rhamnosyl), 3.04 - 3.86 (m, remaining sugar protons)
and 0.98 (3H, d, J = 6 Hz, CH3 rhamnosyl). 13C
NMR (DMSO-d6): δ 177.29 (C-4); 165.28 (C-7);
161.21 (C-5); 160.00 (C-4'), 156.78 (C-9); 156.66
(C-2); 133.22 (C-3); 130.94 (C-2', C-6'); 120.94
(C-1'); 115.18 (C-3', C-5'); 103.67 (C-10); 101.50
(C-1''); 100.85 (C-1'''); 99.10 (C-6); 93.98 (C-8); 76.41
(C-3''); 75.76 (C-5''); 74.24 (2''), 71.87 (C-4'''), 70.65
(C-3'''), 70.41 (C-2'''), 69.96 (C-4''), 68.33 (C-5''');
66.97 (6''); and 17.82 (C-6''').
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Amorphous yellow powder, Rf values ×100: 70
(system: BAW (n-BuOH: HOAc: H2O, 3:3:1)); 1H-
NMR (DMSO-d6): δ 12.6 (1H, s, OH-5), 7.58 (2H, d,
J= 9 Hz, H-2' and H-6'), 6.84 (2H, d, J= 9 Hz, H-5'),
6.40 (1H, d, J= 2 Hz, H-8), 6.19 (1H, d, J= 2 Hz,
H-6), 5.43 (1H, d, J= 7 Hz, H-1'' anomeric proton of
glucosyl), 3.09 - 3.70 (m, remaining sugar protons).
13C NMR (DMSO-d6): δ 177.56 (C-4); 164.45 (C-7);
161.33 (C-5); 156.49, 156.35 (C-2, C-9); 148.64
(C-4'); 144.97 (C-3'); 133. 45 (C-3); 121.78 (C-6');
121.25 (C-1'); 116.29 (C-5'); 115.36 (C-2'); 104.05
(C-10); 101.02 (C-1''); 98.89 (C-6); 93.73 (C-8); 77.65
(C-5''); 76.56 (C-3''); 74.19 (C-2''); 70.01 (C-4''); 61.05
(C-6'').
Determination of total flavonoid content
The total content of flavonoids was determined using
the spectrophotometric method described by Tomczyk
et al. [15]. The results were expressed as mg of quer-
cetin equivalents (QE) per 100 mg of fraction.
Cell lines
Four tumor cell lines, HT-29 (human colon adenocar-
cinoma), A-549 (non-small cell line carcinoma), HepG-
2 (hepatocellular carcinoma) and MCF-7 (human breast
adenocarcinoma) and one normal cell line, MDBK (bo-
vine kidney cells) were obtained from Pasture Institute
of Iran, Tehran, Iran.
All cell lines were grown in suitable media supple-
mented with 10% fetal bovine serum (FBS) and 1%




bromide) colorimetric assay is used to assess cell viability
in the presence of different extracts [16]. Cells were seeded
into 96-well plates and incubated for 24 h at 37°C. Then
the medium was replaced with fresh medium containing
different concentrations of test extracts. After 72 h incuba-
tion at 37°C, the medium was changed by fresh medium
containing MTT and incubated for additional 4 h. There-
after, MTT was removed and remaining formazan crystals
were completely dissolved in DMSO. Afterwards, the ab-
sorbance was recorded at 570 nm, using an ELISA reader.
The inhibitory rate was calculated by the following formula:
Relative viability (%) = (Absorbance test/Absor-
bance control) ×100. IC50 value was defined as the con-
centration of the extract to produce a 50% reduction in
viability of cells relative to the negative control (wells
exposed to the solvent without any extract). All experi-
ments were performed in triplicate. Tamoxifen was used
as positive control.Results and discussion
Results of MTT assay were presented in Table 2 as IC50
values in μg mL-1 and selectivity indexes. Based on this re-
sults, the highest anticancer activity revealed in crude seed
extract of Persian lilac against HT29 (IC50: 8.18 μg mL
-1),
ethyl acetate fraction of neem leaves against HT29 (IC50:
18.63 μg mL-1) and crude leaf extract of neem against
MCF7 (IC50: 34.11 μg mL
-1). It is noticeable that the
mentioned extracts displayed relatively higher selectivity
to mentioned cancer cell lines compared to tamoxifen.
Furthermore, among twelve tested samples, seed kernel
extract of M. azedarach showed the best cytotoxic activity
and selectivity. Hong-Bing et al. reported three limonoids
and two triterpenes from seed of Persian lilac [17]. More-
over, a new euphane triterpenoid reported by Kelecom
et al. [18]. Cabral et al. showed presence of four lignans in
the seed of Persian lilac, which have anti-moulting activity
[19]. However, no cytotoxic activity has been reported so
far from isolated compounds or crude extract of Persian
lilac seeds.
The results in Table 2 also indicated that crude pulp and
crude leaf extracts of A. indica, in contrast to its seed ex-
tract, showed remarkably stronger anti-prolifrative activity
than those of M. azedarach. Moreover, in comparison
with Persian lilac, most of neem samples exhibited rela-
tively lower IC50 on normal cell line, which indicated that
neem is more harmful than Persian lilac and its prescrip-
tion in high doses need more caution.
It is also noticeable that methanol leaf fractions of both
species were inactive against studied cancer cell lines at
concentrations blow 1000 μg mL-1 and their toxicities on
normal line especially that of Persian lilac were less than
other leaf fractions. Based on these results as well as the
yields of fractions, Persian lilac methanol fraction was se-
lected for active compound isolation. Another point is
that traditional herbal medicines are generally prepared as
infusions, decoctions, bath formulations and so on in
which polar compounds are mostly extracted and lead to
pharmacological effects. The methanol fraction as most
polar fraction of the leaves is expected to contain foresaid
active components more than others.
The phytochemical study led to the isolation of four fla-
vonoids including rutin, kaempferol-3-O-robinobioside,
kaempferol-3-O-rutinoside and isoquercetin along with a
purin nucleoside, β-adenosine (Figure 1). All the deriva-
tives were identified by comparing their chemical and
spectral data with that of published literatures [20,21].
As mentioned, most of previous phytochemical and
pharmacological investigations have focused on limonoids
and other triterpenoids as active components of M.
azedarach. Nevertheless, phenolic compounds in particu-
lar flavonol glycosides are present in this plant in high
levels and it seems that they are significantly involved
in the medicinal effects of this plant. Analysis of total
Table 2 Anticancer activity of M. azedarach and A. indica extracts and fractions on different cell lines
Sample Cell lines
MCF7 HepG2 A549 HT29 MDBK
IC50* SI IC50 SI IC50 SI IC50 SI IC50
C. Seed E. 1 33.41 1.20 34.91 1.15 60.10 0.67 8.18 4.90 40.13
2 270.58 - >650 - 370.69 - 343.28 - >650
C. Pulp E. 1 >650 ** - >650 - >650 - >650 - >650
2 139 0.83 212.16 0.54 83.45 1.38 83.49 1.38 115.47
C. Leaf E. 1 >650 - >650 - >650 - 218.61 0.89 195.8
2 34.11 2.06 95.51 0.73 55.84 1.25 38.44 1.82 70.27
Chloroform F. 1 ND - ND - ND - ND - ND
2 38.94 1.13 74.94 0.59 54.59 0.81 46.22 0.95 44.11
Ethyl acetate F. 1 147.9 0.59 210.3 0.42 146.26 0.60 48.91 1.79 87.56
2 56.29 0.93 49.11 1.07 55 0.95 18.63 2.82 52.55
Methanol F. 1 >1000*** - >1000 - >1000 - >1000 - 493.81
2 >1000 - >1000 - >1000 - >1000 - 193.3
Tomoxifen 3.60 1.22 5.8 0.76 10.7 0.41 2.5 1.79 4.4
SI selectivity index, C. crude, E. extract, F. fraction, 1: M. azedarach L., 2: A. indica, ND not detected due to its insolubility;
* IC50 values were calculated in μg mL
-1.
** The sample was not toxic in concentrations less than 650 μg mL-1 and insoluble in concentrations more than it.
*** The sample was not toxic in concentrations less than 1000 μg mL-1.
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lilac and neem showed that they both contained high
levels of flavonols (72.6 mg QE/100 mg of fraction and
77.8 mg QE/100 mg of fraction respectively). Taking look
at the previous reports on medicinal effects of the isolated
flavonols shows that they can be responsible for many ef-
fects which are listed in Table 1. For instance, flavonols as
quercetin, kaempferol and their glycosides can be used as
antidote for a broad range of toxic materials as snake
venoms [22,23], heavy metals, T2 toxin [24], bacterial(1): β-adenosine
Figure 1 Molecular structure of the isolated compounds from M. azedtoxins (e.g. Microcystin, botulinum neurotoxin) [25,26],
mustard [27], bisphenol A [28], arsenic [29]. In addition,
rutin and quercetin were reported to ameliorate inflam-
matory bowel disease [30]. This effect may be associated
with the traditional prescription of Persian lilac for
chronic intestinal obstructions. Also, rutin and quercetin
are able to enhance wound healing [31,32] so that they are
effective in treatment of suppurative wounds [33]. Rutin
has showed anthelmintic activity against human lymphatic
filariasis [34] and Haemonchus contortus [35]. Moreover,(2): R1- OH, R2-O-α-L-rhamnopyranosyl-(1 6)-
β-D-glucopyranoside
(3): R1-H, R2-O-α-L-rhamnopyranosyl -
(1 6)-β-D-galactopyranoside
(4):R1= H, R2-O-α-L-rhamnopyranosyl-(1 6)-β-
D-glucopyranoside
(5): R1-OH, R2-O-β -D-glucopyranoside
arach.
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uretic activity [36] which was found to be mediated by the
action at A1 adenosine receptors like caffeine and theo-
phylline [37]. This activity can be a helpful factor in kidney
stone treatment too [38]. As a remedy for vitiligo, quer-
cetin has potential to enhance melanogenesis on human
epidermis by affecting on maturation of melanosomes
[39] and increase the activity and biosynthesis of tyrosin-
ase in melanoma cells and in human melanocytes [40].
Regarding to hair growth, this compound was reported to
treat and prevent of alopecia areata [41] and inhibit of
5 α-reductase [42].
Conclusion
Our study determined the anti-prolifrative potentials of
extracts from different parts of M. azedarach and A. indica.
Some extracts such as seeds extract of M. azedarach are
strongly and selectively able to induce cell death of studied
cell lines. Methanol leaf fractions were found to be safer in
terms of cytotoxicity and abundant in flavonols. Although
these plants are famous for their limonoids, it seems flavo-
nols can be in charge for many medicinal effects of leaves
of the plants. The present study therefore can provide new
context for further researches.
It should be noted that in the present study, cytotoxic
assay by means of cell culture as an In vitro model can-
not assuredly confirm safety or toxicity of the extracts
[43]. Although the mentioned plants have been used as
traditional medicines for centuries, they are abundant
in cytotoxic, insecticide and pesticide compounds. So,
performing further in vivo animal and human assays is
suggested to confirm the safeties of these plants in
different aspects.
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